A Phase 3, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of SkQ1 Ophthalmic Solution for the Treatment of Dry Eye Syndrome
Phase of Trial: Phase III
Latest Information Update: 22 Nov 2019
Price : $35 *
At a glance
- Drugs Plastoquinonyl-decyl-triphenylphosphonium (Primary)
- Indications Dry eyes
- Focus Registrational; Therapeutic Use
- Acronyms VISTA-1
- Sponsors Mitotech
- 19 Nov 2019 Status changed from active, no longer recruiting to completed.
- 02 Jan 2019 Status changed from recruiting to active, no longer recruiting.
- 10 Dec 2018 New trial record